FDA-Approved Inhibitors of RTK/Raf Signaling Potently Impair Multiple Steps of In Vitro and Ex Vivo Influenza A Virus Infections.

Autor: Meineke, Robert1 (AUTHOR), Stelz, Sonja1 (AUTHOR), Busch, Maximilian1 (AUTHOR), Werlein, Christopher2 (AUTHOR), Kühnel, Mark2,3 (AUTHOR), Jonigk, Danny2,3 (AUTHOR), Rimmelzwaan, Guus F.1 (AUTHOR), Elbahesh, Husni1 (AUTHOR) husni.elbahesh@tiho-hannover.de
Zdroj: Viruses (1999-4915). Sep2022, Vol. 14 Issue 9, p2058-N.PAG. 19p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje